Get started

Buystock

CVS is a good buyfor risk-takers this for you, CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager and Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island. By looking at the company file we got this total assets 12/30/2020 12/30/2019 12/30/2018 12/30/2017 230,7 B 222,4B 196,4B 95,1B Increasing percent from the year before. 3.73% in 2020 13.23 % in 2019 106.51% in 2018 The total debt 85,0B 89,0 B 73,4 B 27,0 B percentage change from the year before -4.49 % in 2020 +21.25 % in 2019 +171.85 % in 20218 --------------------------------------------- Debt percentage from assets 36.86% 40.01% 37.37% 28.39% Net Income 7,57B 7,18 B 6,63 B -0.594 B 6,62 B EBIT 12,64 B 12,67 B 12,03 B 4,02 B 9,33 B Free cash flow 15,19 B 13,43 B 10,39 B 6,83 B 6,09 B Return on Investment 5YA 4.12% for the company 6.44 for the sector Return on Assets 5YA 3.06% for the company 5.83 for the sector 5 Year EPS Growth 5YA 3.33% for the company 16.84 for the sector 5 Year Sales Growth 5YA 11.88% for the company 12.01 for the sector Dividend Yield ANN 2.15% for the company 1.37 for the sector Final view After reviewing the company file, we express our opinion as the assets are continuously increasing so the net income, free cash flow which is a good sign by looking at the 5-year ratios we see the company is growing The dividend ratio is perfect for the shareholders who own the shares for long-term investment. the total debt is fine we can see it increasing but in the long run, I believe It will not be a problem for the company. the company performance Improved with the spread of the pandemic, still, I think the pandemic will increase in the coming period as we see omicron news. CVS is a good buy now
NYSE:CVSLong
by youssefallax
GPL on buy Great Panther Mining Limited (GPL) entered the buy zone, based on the fundamental analysis I see the company start to recover from the -55% price drawdown since January 2021. I see the net income has made a great height '' 21,858 K '' this year than 2020 '' 334 K '' with +6544 % Increase. As shown on the company Income statement on Yahoo Finance the EBITDA is '' 66,737 K'' For 2021 after more than 5 years of nothing. - - - I can see that the company had reduced the free cash flow to be ''1,397 K'' than ''26,941 K'' for 2020 with a -94.8 % decrease. The total debt, this year, is '' 44,619 K '' than the 2020 year '' 60,679 K '' -26.47% decreasing percentage which is good for the company. Technically I can see volume increasing based on the volume moving average at the beginning of 2019. The price is going to reach 0.33 - 0.23 support areas, probably the 17.67% top Institutional Holders will provide liquidity at these levels, I expect the Renko trend to start changing trend in the coming weeks for the bullish trend, 1.06 - 1.16 is our target as a strong resistance.
GLong
by youssefallax